BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26277549)

  • 41. The prognostic impact of IKZF1 deletions and UKALL genetic classifiers in paediatric B-cell precursor acute lymphoblastic leukaemia treated according to NOPHO 2008 protocols.
    Öfverholm I; Rezayee F; Heyman M; Harila A; Arvidsson L; Schmiegelow K; Norén-Nyström U; Barbany G
    Br J Haematol; 2023 Jul; 202(2):384-392. PubMed ID: 37156607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia.
    Rand V; Parker H; Russell LJ; Schwab C; Ensor H; Irving J; Jones L; Masic D; Minto L; Morrison H; Ryan S; Robinson H; Sinclair P; Moorman AV; Strefford JC; Harrison CJ
    Blood; 2011 Jun; 117(25):6848-55. PubMed ID: 21527530
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved cytogenetic characterization and risk stratification of pediatric acute lymphoblastic leukemia using single nucleotide polymorphism array analysis: A single center experience of 296 cases.
    Olsson L; Lundin-Ström KB; Castor A; Behrendtz M; Biloglav A; Norén-Nyström U; Paulsson K; Johansson B
    Genes Chromosomes Cancer; 2018 Nov; 57(11):604-607. PubMed ID: 30203896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions.
    Clappier E; Auclerc MF; Rapion J; Bakkus M; Caye A; Khemiri A; Giroux C; Hernandez L; Kabongo E; Savola S; Leblanc T; Yakouben K; Plat G; Costa V; Ferster A; Girard S; Fenneteau O; Cayuela JM; Sigaux F; Dastugue N; Suciu S; Benoit Y; Bertrand Y; Soulier J; Cavé H
    Leukemia; 2014 Jan; 28(1):70-7. PubMed ID: 24064621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?
    Palmi C; Valsecchi MG; Longinotti G; Silvestri D; Carrino V; Conter V; Basso G; Biondi A; Kronnie GT; Cazzaniga G
    Haematologica; 2013 Aug; 98(8):1226-31. PubMed ID: 23585525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia.
    Braun M; Pastorczak A; Fendler W; Madzio J; Tomasik B; Taha J; Bielska M; Sedek L; Szczepanski T; Matysiak M; Derwich K; Lejman M; Kowalczyk J; Kazanowska B; Badowska W; Styczynski J; Irga-Jaworska N; Trelinska J; Zalewska-Szewczyk B; Pierlejewski F; Wlodarska I; Młynarski W;
    Leuk Lymphoma; 2017 May; 58(5):1162-1171. PubMed ID: 27756164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Using MS-MLPA as an efficient screening tool for detecting 9p21 abnormalities in pediatric acute lymphoblastic leukemia.
    Gardiner RB; Morash BA; Riddell C; Wang H; Fernandez CV; Yhap M; Berman JN
    Pediatr Blood Cancer; 2012 Jun; 58(6):852-9. PubMed ID: 21796768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cooperative genetic changes in pediatric B-cell precursor acute lymphoblastic leukemia with deletions or mutations of IKZF1.
    Olsson L; Albitar F; Castor A; Behrendtz M; Biloglav A; Paulsson K; Johansson B
    Genes Chromosomes Cancer; 2015 May; 54(5):315-25. PubMed ID: 25727050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic significance of copy number alterations detected by multi-link probe amplification of multiple genes in adult acute lymphoblastic leukemia.
    Fang Q; Yuan T; Li Y; Feng J; Gong X; Li Q; Zhao X; Liu K; Tang K; Tian Z; Zhang Q; Wang Y; Liu B; Wang M; Ru K; Wang J; Mi Y
    Oncol Lett; 2018 Apr; 15(4):5359-5367. PubMed ID: 29552179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical significance of recurrent copy number aberrations in B-lineage acute lymphoblastic leukaemia without recurrent fusion genes across age cohorts.
    Messina M; Chiaretti S; Fedullo AL; Piciocchi A; Puzzolo MC; Lauretti A; Gianfelici V; Apicella V; Fazi P; Te Kronnie G; Testi AM; Vitale A; Guarini A; Foà R
    Br J Haematol; 2017 Aug; 178(4):583-587. PubMed ID: 28439887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray study.
    Baughn LB; Biegel JA; South ST; Smolarek TA; Volkert S; Carroll AJ; Heerema NA; Rabin KR; Zweidler-McKay PA; Loh M; Hirsch B
    Cancer Genet; 2015; 208(1-2):1-18. PubMed ID: 25678190
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RAS pathway mutation is an added-value biomarker in pediatric Philadelphia-negative B-cell acute lymphoblastic leukemia with IKZF1 deletions.
    Huang YJ; Liu HC; Jaing TH; Wu KH; Wang SC; Yen HJ; Hsiao CC; Chen SH; Lin PC; Yeh TC; Sheen JM; Chen YC; Chang TK; Huang FL; Chao YH; Hou JY; Yang CP; Lin TH; Shih LY
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28899. PubMed ID: 33522704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular inversion probes reveal patterns of 9p21 deletion and copy number aberrations in childhood leukemia.
    Schiffman JD; Wang Y; McPherson LA; Welch K; Zhang N; Davis R; Lacayo NJ; Dahl GV; Faham M; Ford JM; Ji HP
    Cancer Genet Cytogenet; 2009 Aug; 193(1):9-18. PubMed ID: 19602459
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study.
    Kim M; Yim SH; Cho NS; Kang SH; Ko DH; Oh B; Kim TY; Min HJ; She CJ; Kang HJ; Shin HY; Ahn HS; Yoon SS; Kim BK; Shin HR; Han KS; Cho HI; Lee DS
    Cancer Genet Cytogenet; 2009 Nov; 195(1):59-65. PubMed ID: 19837270
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution.
    Waanders E; Scheijen B; van der Meer LT; van Reijmersdal SV; van Emst L; Kroeze Y; Sonneveld E; Hoogerbrugge PM; van Kessel AG; van Leeuwen FN; Kuiper RP
    PLoS Genet; 2012; 8(2):e1002533. PubMed ID: 22359517
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microarray testing as an efficient tool to redefine hyperdiploid paediatric B-cell precursor acute lymphoblastic leukaemia patients.
    Lejman M; Zawitkowska J; Styka B; Babicz M; Winnicka D; Zaucha-Prażmo A; Pastorczak A; Taha J; Młynarski W; Kowalczyk JR
    Leuk Res; 2019 Aug; 83():106163. PubMed ID: 31202078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic gene alterations and clonal changes in childhood B-ALL.
    Erbilgin Y; Firtina S; Mercan S; Hatirnaz Ng O; Karaman S; Tasar O; Karakas Z; Celkan TT; Zengin E; Sarper N; Yildirmak ZY; Sisko S; Ozbek U; Sayitoglu M
    Leuk Res; 2019 Aug; 83():106159. PubMed ID: 31228652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia.
    Qazi S; Uckun FM
    Haematologica; 2013 Dec; 98(12):e151-2. PubMed ID: 24323986
    [No Abstract]   [Full Text] [Related]  

  • 59. Genomic analysis of adult B-ALL identifies potential markers of shorter survival.
    Patel S; Mason CC; Glenn MJ; Paxton CN; South ST; Cessna MH; Asch J; Cobain EF; Bixby DL; Smith LB; Reshmi S; Gastier-Foster JM; Schiffman JD; Miles RR
    Leuk Res; 2017 May; 56():44-51. PubMed ID: 28193567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Copy Number Alterations are Associated with the Risk of Very Early Relapse in Pediatric B-lineage Acute Lymphoblastic Leukemia: A Nested Case-control MIGICCL Study.
    Rosales-Rodríguez B; Núñez-Enríquez JC; Velázquez-Wong AC; González-Torres C; Gaytán-Cervantes J; Jiménez-Hernández E; Martín-Trejo JA; Campo-Martínez MLÁD; Medina-Sanson A; Flores-Lujano J; Flores-Villegas LV; Peñaloza-González JG; Torres-Nava JR; Espinosa-Elizondo RM; Amador-Sánchez R; Miranda-Madrazo MR; Santillán-Juárez JD; Pérez-Saldívar ML; Gurrola-Silva A; Orozco-Ruiz D; Solís-Labastida KA; Velázquez-Aviña MM; Duarte-Rodríguez DA; Mata-Rocha M; Sepúlveda-Robles OA; Ortiz-Maganda M; Bekker-Méndez VC; Jiménez-Morales S; Mejía-Aranguré JM; Rosas-Vargas H
    Arch Med Res; 2021 May; 52(4):414-422. PubMed ID: 33541741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.